# Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers

> **NCT01997879** · PHASE1 · COMPLETED · sponsor: **Aerie Pharmaceuticals** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AR-13324 Ophthalmic Solution, 0.02%

## Key facts

- **NCT ID:** NCT01997879
- **Lead sponsor:** Aerie Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01997879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01997879, "Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01997879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*